GeneOne Life Science and Inovio Pharmaceuticals to Collaborate on Zika Virus Vaccine Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Maxim Positive on Inovio Pharma's (INO) Zika Virus Vaccine Collaboration; Reaffirms at 'Buy'
January 22, 2016 10:03 AM ESTMaxim affirms Inovio Pharmaceuticals (Nasdaq INO) with a Buy rating and $14 price target after the company announced a new collaboration with GeneOne... More
Inovio Pharma (INO) Goins Amid New Zika Virus Vaccine Collaboration
January 22, 2016 9:41 AM ESTInovio Pharmaceuticals (Nasdaq: INO) shares are up early after it and GeneOne Life Science entered a... More
